Definitely you are eager to know how you are burning your calories for your weight loss concern. Ever since I was little; I have always wondered why all athletes kept looking at their watches. I thought that they were timing themselves to see how long they can take to run the competition distance. Little did […]
Mon
28
Apr
Pfizer has entered into a collaboration agreement with four major research universities - University of California, Santa Barbara (UCSB); Caltech; the Massachusetts Institute of Technology; and University of Massachusetts - and Entelos, a physiological modeling company, to re-examine the regulatory mechanisms of human energy metabolism. Pfizer is funding the three-year and $14 million Insulin Resistance […]
0 comments admin | Diabetes |
Merck Sharp & Dohme Limited (MSD) announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for ‘Tredaptive’™ (nicotinic acid/laropiprant, MSD) 1000 mg / 20 mg modified-release tablets for the treatment of mixed dyslipidaemia and primary hypercholesterolaemia. ‘Tredaptive’, the name of ‘Cordaptive’™ (ER niacin/laropiprant) in the European Union (EU), […]
0 comments admin | Diabetes |
GlaxoSmithKline (GSK) announced that the European Commission has issued marketing authorisation for Volibris® (ambrisentan) for the treatment of Pulmonary Arterial Hypertension (PAH) in patients classified as World Health Organisation (WHO) Functional Class II and III, to improve exercise capacity. [i] Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective […]
Mon
28
Apr
Researchers have mapped out a region on human chromosome 1 that contributes to genetically elevated blood triglyceride levels, a major risk factor for heart disease.
Triglycerides (TG), the main form of dietary fat, continuously circulate in the blood, but if their concentration elevates the risk of atherosclerosis and subsequently heart disease increases. Circulating TG levels depend […]
Doctors are aware of a range of risk factors, mostly related to the patients’ family history, overweight, and lifestyle, that contribute to the risk of developing type 2 diabetes. Now researchers at the University of Warwick have found markers that indicate endothelial dysfunction (changes in the cells which line the blood vessels) and sub-clinical systemic […]
Minimally invasive heart bypass surgery using a DaVinci robot means a shorter hospital stay and faster recovery for patients, as well as fewer complications and a better chance that the new bypass vessels will stay open. And, according to a University of Maryland study, robotic heart bypass surgery also makes good economic sense for hospitals. […]
Proteus Biomedical Inc., a pioneer in intelligent medicine, announced the initiation of the RETIME 2.0 (Resynchronization using Electric Tomography to Improve Myocardial Efficiency 2.0) study. RETIME 2.0 is designed to assess the performance of Proteus Biomedical’s cardiac electric tomography (CET) and multi-sensor lead system for the measurement of cardiac performance in heart failure patients undergoing […]
AngioDynamics (NASDAQ:ANGO) reported that the first human clinical use employing irreversible electroporation (IRE) to ablate soft tissue was completely successful based on analysis of biopsies performed on five patients two weeks after their treatment.
The IRE treatment was conducted during the first week of April, 2008 as part of a pilot trial focused on determining […]
Mon
28
Apr
Akorn-Strides, LLC announced the approvals of two ANDAs for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE: STAR)(BSE: 532531). The primary mission for the Joint […]